Yep it’s a b*tch!

Apologies should’ve indicated OT. I shared because I thought good information and that research/information like this potentially reaches many areas of the Covid plight.

Has anyone seen/read this article from 2 days ago on MedScape.

Researchers found that the genetic signal is likely to affect cells in the lung. By finely examining DNA at the site of the genetic signal (LZTFL1 gene) controlled by the so-called 'switch', they identified the gene responsible for the greater risk of developing severe COVID-19.

News > Medscape News UK
Gene Identified for High Risk of COVID Mortality Much More Common in South Asians

Becky McCall
November 05, 2021
1
A gene that doubles the risk of respiratory failure and death from COVID-19, and is present in 60% of South Asians, but only 15% of Europeans, has been identified and might explain the excess deaths in some ethnic groups over others.

Researchers from Oxford University led by James Davies, consultant in intensive care medicine and associate professor of genomics, and Jim Hughes, PhD, professor of gene regulation, both at the University of Oxford's MRC Weatherall Institute of Molecular Medicine, used an artificial intelligence algorithm to analyse huge quantities of genetic data from hundreds of types of cells, to show that the gene, leucine zipper transcription factor-like 1 (LZTFL1), is associated with lung function rather than the immune system. The study findings are published in Nature Genetics.

Has anyone seen/read this article from 2 days ago on MedScape.

Researchers found that the genetic signal is likely to affect cells in the lung. By finely examining DNA at the site of the genetic signal (LZTFL1 gene) controlled by the so-called 'switch', they identified the gene responsible for the greater risk of developing severe COVID-19.

News > Medscape News UK
Gene Identified for High Risk of COVID Mortality Much More Common in South Asians

Becky McCall
November 05, 2021
1
A gene that doubles the risk of respiratory failure and death from COVID-19, and is present in 60% of South Asians, but only 15% of Europeans, has been identified and might explain the excess deaths in some ethnic groups over others.

Researchers from Oxford University led by James Davies, consultant in intensive care medicine and associate professor of genomics, and Jim Hughes, PhD, professor of gene regulation, both at the University of Oxford's MRC Weatherall Institute of Molecular Medicine, used an artificial intelligence algorithm to analyse huge quantities of genetic data from hundreds of types of cells, to show that the gene, leucine zipper transcription factor-like 1 (LZTFL1), is associated with lung function rather than the immune system. The study findings are published in Nature Genetics.

Has anyone seen/read this article from 2 days ago on MedScape.

Researchers found that the genetic signal is likely to affect cells in the lung. By finely examining DNA at the site of the genetic signal (LZTFL1 gene) controlled by the so-called 'switch', they identified the gene responsible for the greater risk of developing severe COVID-19.

News > Medscape News UK
Gene Identified for High Risk of COVID Mortality Much More Common in South Asians

Becky McCall
November 05, 2021
1
A gene that doubles the risk of respiratory failure and death from COVID-19, and is present in 60% of South Asians, but only 15% of Europeans, has been identified and might explain the excess deaths in some ethnic groups over others.

Researchers from Oxford University led by James Davies, consultant in intensive care medicine and associate professor of genomics, and Jim Hughes, PhD, professor of gene regulation, both at the University of Oxford's MRC Weatherall Institute of Molecular Medicine, used an artificial intelligence algorithm to analyse huge quantities of genetic data from hundreds of types of cells, to show that the gene, leucine zipper transcription factor-like 1 (LZTFL1), is associated with lung function rather than the immune system. The study findings are published in Nature Genetics.

Moving back up......38's in play

Low volume day

SHORT INTEREST
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
10/15/2021 29,858 -75.91 1,149,552 1 No No
09/30/2021 123,955 295.11 914,173 1 No No
09/15/2021 31,372 -26.94 1,936,275 1 No No
08/31/2021 42,938 200.27 1,138,152 1 No No
08/13/2021 14,300 31.36 4,121,551 1 No No
07/30/2021 10,886 -71.23 1,289,835 1 No No
07/15/2021 37,839 -74.08 2,316,049 1 No No
06/30/2021 145,964 -66.92 1,936,435 1 No No
06/15/2021 441,244 -45.96 1,496,116 1 No No
05/28/2021 816,823 -0.03 1,588,429 1 No No

OTCMarkets.com

SHORT INTEREST UPDATE
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
10/15/2021 29,858 -75.91 1,149,552 1 No No
09/30/2021 123,955 295.11 914,173 1 No No
09/15/2021 31,372 -26.94 1,936,275 1 No No
08/31/2021 42,938 200.27 1,138,152 1 No No
08/13/2021 14,300 31.36 4,121,551 1 No No
07/30/2021 10,886 -71.23 1,289,835 1 No No
07/15/2021 37,839 -74.08 2,316,049 1 No No
06/30/2021 145,964 -66.92 1,936,435 1 No No
06/15/2021 441,244 -45.96 1,496,116 1 No No
05/28/2021 816,823 -0.03 1,588,429 1 No No

1.5mm shares now traded

More than a 1mm plus shares traded so far, up 10%+, and a 6:1 on the BUY

Hopefully a start to RECOVERY.....ready to move back up....

IPIX is currently the #1 Most Read board on IHUB. Lots of eyes....

https://investorsprism.com/death-by-fda/

@yahoo

National Institutes of Health (NIH) Director Dr. Francis Collins confirmed in a public forum that three such drugs from small, innovative biotech companies, Leronlizumab, Lenzilumab, and Aviptadil are among the few viable candidates for treating COVID-19 of the more than 750 compounds screened by the National Institutes of Health. Yet, inexplicably, despite clear early evidence of efficacy Leronlizumab and Lenzilumab have been denied EUA and Aviptadil has been awaiting an EUA decision already for 150 days.

Holding with you Lakota...not much but 550,000.

I just gotta say it….this is bullshit!!

Excited for ipix opportunities! Should be great 2022.

My dumb ass held. Doing quite well with rvvtf but lost most, solid gains in the other. Bought at .03 though so hanging on.

Looks like…

Rvvtf and RLFTF? Me too…

Nice afternoon action

Nice action this morning

Both CDEL and JANE mm on this.....GEEZE!

Nice day today. Great way to start the week!

Pretty pathetic today

What the heck is going on with the stock? Completely petered out!

????

Thanks. Possible limit trades.

Good to know

Could new shares be flooding the market?

Nicely….Would love to hang on to gain

Good read. https://techcrunch.com/2021/01/25/president-joe-biden-commits-to-replacing-entire-federal-fleet-with-electric-vehicles/

Agree….excellent video and nice forecast.

Well I'll be....we managed to close above .30! Good times!!

Nice! Would be better if we were pr’d accordingly. Spread the gospel so to speak.

Nice movement today.

PW…Thanks fir posting.

He has a lot going forward him

As such, he graduated Summa Cum Laude with a 3.95 GPA and earned a total of six undergraduate degrees before pursuing his medical degree. After graduating medical school, he enrolled in a Master’s program for public health, thus working towards his eighth and final degree.

Yep!

Repost from @yahoo David Triplett